Neuros Medical

Executive Summary

Neuros Medical is a medical device company focused on neuromodulation for chronic pain. Its flagship product, the Altius Direct Electrical Nerve Stimulation System, is FDA-approved for managing chronic post-amputation pain in lower limb amputees. The implantable, patient-controlled device offers a novel approach to a debilitating condition affecting tens of thousands of amputees annually. With FDA clearance, Neuros Medical is positioned to capture a niche but significant market; however, commercial success hinges on reimbursement, clinician adoption, and market education. The company is also exploring expansion into additional pain indications, which could broaden its addressable market and drive future growth.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Altius to other amputation levels and pain types60% success
• Q3 2026Reimbursement coverage decision from major payers70% success
• Q2 2027Strategic partnership for commercialization or distribution50% success